infections showing no apparent symptoms. 3, 7, 8 When symptomatic, infection is often characterized by oral or facial lesions, that is at the initial portal of entry. 6, 7 HSV-1 infection is associated with oral, cutaneous, ocular, and central nervous system manifestations, and thus infection can lead to mild to serious or severe morbidity, such as gingivostomatitis, herpes labialis, herpetic whitlow, neonatal herpes, corneal blindness, meningitis, and encephalitis. 6, 9 HSV-1 can also be transmitted to susceptible persons through oral sex or sexual intercourse resulting in genital herpes, given the genital portal of initial entry. 3, 7, 10 Recent evidence from Western countries indicates a growing role for HSV-1 as a sexually transmitted infection (STI) and a leading, if not the leading, cause of genital herpes. 7, [11] [12] [13] [14] [15] With continued improvement in hygiene and living conditions, HSV-1 antibody prevalence (seroprevalence) appears to be declining at least in Western countries. 1, 5, [16] [17] [18] [19] [20] [21] [22] HSV-1 seroprevalence has declined by about 30% over the last three decades among adolescents 14-19 years of age in the United States. 8 Evidence suggests that a striking transition in HSV-1 epidemiology, from an oral to increasingly genital infection, is already taking place in Western countries, 7, 8, 23 and is resulting in significant clinical and psychosocial morbidity. 4, 7, [23] [24] [25] In context of limited data on HSV-1 seroprevalence in MENA, 1 the aim of our study was to assess HSV-1 seroprevalence among select MENA national populations and to characterize the infection's age-distribution. Specifically, we assessed HSV-1 seroprevalence among male blood donors, from 11 MENA nationalities, who are currently residing in Qatar. Qatar is a MENA country situated in the Arabian Peninsula with a population of 2.2 million in 2014. 26 Qataris constitute only 12% of the total population, with the vast majority of the population being recent short-term expatriate residents coming for contractual employment for specific number of years.
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With a large fraction of these expatriates coming from other MENA countries, Qatar provided an opportune setting for a comparative study of HSV-1 seroprevalence among different MENA populations. HSV-1 seroprevalence among these expatriates should be comparable to HSV-1 seroprevalence in their home countries.
These expatriates are predominantly recent short-term residents in
Qatar and spent most of their lifetime in their home countries-their seroprevalence should be more representative of the exposure risk in their home countries, rather than in Qatar. HSV-1 seroprevalence among men should also be representative of that among women, as existing global evidence suggests no major sex-specific differences.
1,2
Since HSV-1 is mainly transmitted orally with a general-population epidemiology, we would further expect that the seroprevalence among blood donors should be comparable to that in the wider population, as supported also by existing evidence. For estimating HSV-1 age-specific seroprevalence, a random sample of 50 subjects per age group was selected for each of Egypt, the Fertile Crescent (Iraq, Jordan, Lebanon, Palestine, and Syria), and Qatar (Table 1) . If serum was not sufficient for a subject, a replacement subject was randomly chosen with the same nationality and age group. There were not always sufficient subjects or serum to conduct the serology to reach the 50 target sample size per age category. Due to insufficient sample size in each country individually, the neighboring countries of Iraq, Jordan, Lebanon, Palestine, and Syria were merged together as one national unit, the Fertile Crescent, as they share similar socio-economic and socio-cultural attributes. No sufficient sample size was available to assess the age-specific seroprevalence in other countries.
For estimating country-specific HSV-1 seroprevalence in countries where we did not have sufficient sample size to estimate the age-specific seroprevalence, a random sample of 200 subjects was selected for each of Jordan, Pakistan, Palestine, and Syria. For Iran, Lebanon, Sudan, and Yemen, all available specimens were included in the study sample, as <200
were available for each of these countries (Table 1 ). For countries with <100 subjects, no country-specific estimate was conducted (Algeria, Iraq, Morocco, Oman, and Tunisia).
| Biological sample collection and laboratory analysis
A portion of sera (50 μL) was aliquoted from existing sera samples that were stored at −80°C until used for serology testing. Sera were tested for the presence of anti-HSV-1 IgG using HerpeSelect ® 1 enzyme linked immunosorbent assay (ELISA) kits (Cat. No. EL0910G-5, Focus Diagnostics).
This kit was designed for qualitative detection of type-specific IgG antibodies to HSV-1 in human serum using a 96-microwell polystyrene plate coated with a purified recombinant HSV-1 glycoprotein-G antigen (gG1 
| RESULTS
In total, 2,077 serum specimens from subjects from 11 MENA countries were tested for HSV-1 antibodies ( Both age and nationality were found to be associated factors with HSV-1 infection in both univariable and multivariable analyses (Table 4 ). There was a significant positive association between seroprevalence and age in the univariable analysis. Compared to those aged ≤24 years, all older age groups had higher seroprevalence. The crude prevalence ratios (PRs) increased from 1.11 (95% CI Our results indicated variation in HSV-1 seroprevalence across countries, and observed rates are consistent with the global evidence suggesting an association between HSV-1 infection and socio-economic status. 1, 8 Seroprevalence was higher in the lower-income countries of Egypt, Sudan, and Yemen, than in the relatively higher-income countries of Iran, Jordan, Lebanon, Palestine, Qatar, and Syria. A recent study from Saudi Arabia, a higher-income country, found also a seroprevalence similar to our results for the higher-income countries. 31 Pakistan though was a notable exception by being a lower seroprevalence (77%) and also a lower-income country. This finding remains to be confirmed and explained, but we are not aware of other comparable HSV-1 studies from Pakistan. Of note, however, HSV-1 seroprevalence in India, a neighboring country of Pakistan with similar socio-economic level, was reported to be at only 60%. 2 These results may hint that the association between HSV-1 infection and socio-economic status is more nuanced than previously thought.
Our study has limitations. The specimens were only from male blood donors with no population-and probability-based sampling, exposing the study to potential selection bias. Specimens were collected from individuals of different nationalities, but all individuals were residing in Qatar at that time. HSV-1 seroprevalence among TABLE 3 Estimates of HSV-1 age-specific seroprevalence among male blood donors currently residing in Qatar but from Egypt, the Fertile Crescent (including Iraq, Jordan, Lebanon, Palestine, and Syria), and Qatar | 187 these expatriates may not necessarily reflect the seroprevalence in their home countries. Very basic socio-demographic variables were collected, limiting our ability to assess relevant individual-level associations such as education, socio-economic status, or specific socio-cultural practices. Two different methods were used to select the testing samples depending on primary purpose, overall versus age-specific seroprevalence. For the overall seroprevalence, we chose the specimens randomly among all specimens for that nationality.
Meanwhile, for the age-specific seroprevalence, we chose a fixed number of specimens (also randomly) for each age group, and then determined the overall seroprevalence in this sample based on the number of positives in all age groups. There is evidence for variation in the sensitivity and specificity of HSV-1 assays by population, 32, 41, 42 thereby potentially affecting the estimated seroprevalence levels.
Despite these limitations, selection bias may be less of an issue for HSV-1, as it is predominantly transmitted orally with a general-population epidemiology. In these blood-donor samples, the bias will probably be towards older populations, given that the median age in MENA countries is most often <25 years of age. 43 Our estimated seroprevalence could be higher than actual seroprevalence, and our Administration, and is among the most commonly used herpes assays in the literature. 32 Lastly, these limitations should be considered in light of the logistical challenges and prohibitive costs to conduct HSV-1 nationally-representative studies on probability-based samples, limitations in availability of HSV-1 epidemiologic data globally, 8 and the present opportunity to conduct this large-scale study by country and age group on existing samples. This is the first time HSV-1 seroprevalence data will appear in the literature for several of the included countries.
In 
